Animal models of diabetic neuropathic pain

Experimental and Clinical Endocrinology and Diabetes

Volumn 122, Issue 2, 2014, Pages 100-106

  Gao, F ^a   Zheng, Z M ^a  

^a FIRST HOSPITAL OF SHIJIAZHUANG   (China)

Author keywords

animal models; diabetes; neuropathic pain

Indexed keywords

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; MICE; MICE, KNOCKOUT; NEURALGIA; RATS; RATS, ZUCKER;

EID: 84894423492     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0033-1363234     Document Type: Review

References (95)

1. Bastyr E. J. 3rd, Price K. L., Bril V. the MBBQ Study Group Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther: 2005; 27 1278 1294 (Pubitemid 41393921)
2. Beiswenger K. K., Calcutt N. A., Mizisin A. P. Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett: 2008; 442 267 272
3. Bennett M. I., Attal N., Backonja M. M. et al. Using screening tools to identify neuropathic pain. Pain: 2007; 127 199 203 (Pubitemid 46084881)
4. Benstead T. J., Sangalang V. E. Nerve microvessel changes in diabetes are prevented by aldose reductase inhibition. Can J Neurol Sci: 1995; 22 192 197
5. Bierhaus A., Nawroth P. P. Critical evaluation of mouse models used to study pain and loss of pain perception in diabetic neuropathy. Exp Clin Endocrinol Diabetes: 2012; 120 188 190
6. Bierhaus A., Fleming T., Stoyanov S. et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med: 2012; 18 926 933
7. Bonner-Weir S., Trent D. F., Weir G. C. Responses of neonatal rat islet to streptozotocin. Limited B cell regeneration and hyperglycemia. Diabetes: 1981; 30 64 69 (Pubitemid 11022626)
8. th Camillo Golgi lecture. Diabetologia: 2004; 47 1343 1353 (Pubitemid 39232418)
9. Calcutt N. A. Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol: 2002; 50 205 208
10. Calcutt N. A., Freshwater J. D., Mizisin A. P. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia: 2004; 47 718 724 (Pubitemid 38658374)
11. Cameron N. E., Cotter M. A., Basso M. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia: 1997; 40 271 281 (Pubitemid 27096550)
12. Cameron N. E., Tuck Z., McCabe L. et al. Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Diabetologia: 2001; 44 1161 1169 (Pubitemid 32835509)
13. Cameron N. E., Jack A. M., Cotter M. A. Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic Biol Med: 2001; 31 125 135 (Pubitemid 32568432)
14. Cameron N. E., Gibson T. M., Nangle M. R. et al. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Ann N Y Acad Sci: 2005; 1043 784 792 (Pubitemid 41123973)
15. Chaplan S. R., Bach F. W., Pogrel J. W. et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods: 1994; 53 55 63 (Pubitemid 24238751)
16. Chen S. R., Pan H. L. Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J Neuro-physiol: 2002; 87 2726 2733
17. Chiechio S., Copani A., Gereau R. W. 4th et al. Acetyl-L-carnitine in neuropathic pain: experimental data. CNS Drugs: 2007; 21 (Suppl 1): 31 38
18. Courteix C., Eschalier A., Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain: 1993; 53 81 88 (Pubitemid 23137271)
19. Cotter M. A., Jack A. M., Cameron N. E. Effects of the protein kinase Cb inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes. Clin Sci (Lond): 2002; 103 311 321 (Pubitemid 35007223)
20. Dobretsov M., Hastings S. L., Romanovsky D. et al. Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res: 2003; 960 174 183 (Pubitemid 36044574)
21. Dobretsov M., Ghaleb A. H., Romanovsky D. et al. Impaired insulin signaling as a potential trigger of pain in diabetes and prediabetes. Int Anesthesiol Clin: 2007; 45 95 105 (Pubitemid 46624189)
22. Devor M., Seltzer S. Pathophysiology of Damaged Nerves in Relation to Chronic Pain. London, England Churchill Livingstone: 1999
23. nd ed. NIH Publication 95-1468. Washington, DC National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: 1995
24. Drel V. R., Pacher P., Vareniuk I. et al. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocindiabetic mice. Eur J Pharmacol: 2007; 569 48 58 (Pubitemid 47175883)
25. Drel V. R., Pacher P., Vareniuk I. et al. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes. Int J Mol Med: 2007; 20 783 792
26. Eaton S. E., Harris N. D., Ibrahim S. et al. Increased sural nerve epineurial blood flow in human subjects with painful diabetic neuropathy. Diabetologia: 2003; 46 934 939 (Pubitemid 36961316)
27. Ellis E. A., Grant M. B., Murray F. T. et al. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med: 1998; 24 111 120 (Pubitemid 28006442)
28. Francis G., Martinez J., Liu W. et al. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes: 2009; 58 934 945
29. Guberski D., Butler L., Like A. The BBZ/Wor rat: An obese animal with autoimmune diabetes. In: Shafrir E., Renold A. (eds.). Lessons from Animal Diabetes II. London John Libbe and Company Ltd: 1988; 268 271
30. Hall K. E., Sima A. A., Wiley J. W. Voltage-dependent calcium currents are enhanced in dorsal root ganglion neurones from the Bio Bred/Worchester diabetic rat. J Physiol: 1995; 486 (Pt 2) 313 222
31. Hansson P., Backonja M., Bouhassira D. Usefulness and limitations of quantitative sensory testing: Clinical and research application in neuropathic pain states. Pain: 2007; 129 256 259 (Pubitemid 46778783)
32. Hemmes R. B., Schoch R. High dosage testosterone propionate induces copulatory behavior in the obese male Zucker rat. Physiol Behav: 1988; 43 321 324
33. Ilnytska O., Lyzogubov V. V., Stevens M. J. et al. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes: 2006; 55 1686 1694 (Pubitemid 44324121)
34. Islam M. S., Choi h. Nongenetic model of type 2 diabetes: a comparative study. Pharmacology: 2007; 79 243 249
35. Jafarnejad A., Bathaie S. Z., Nakhjavani M. et al. Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model. Life Sci: 2008; 82 301 307
36. Jolivalt C. G., Vu Y., Mizisin L. M. et al. Impaired prosaposin secretion during nerve regeneration in diabetic rats and protection of nerve regeneration by a prosaposin-derived peptide. J Neuropathol Exp Neurol: 2008; 67 702 710
37. Jolivalt C. G., Lee C. A., Ramos K. M. et al. Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters. Pain: 2008; 140 48 57
38. Kage K., Niforatos W., Zhu C. Z. et al. Alteration of dorsal root ganglion P2X3 receptor expression and function following spinal nerve ligation in the rat. Exp Brain Res: 2002; 147 511 519 (Pubitemid 35440504)
39. Kalichman M. W., Dines K. C., Bobik M. et al. Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes. Brain Res: 1998; 810 130 137 (Pubitemid 29003398)
40. Lenzen S. The mechanisms of allxan- and strptozotcin-induced diabetes. Diabetologia: 2008; 51 216 226
41. Li F., Drel V. R., Szabó C. et al. Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy. Diabetes: 2005; 54 1514 1522 (Pubitemid 40586684)
42. Low P. A., Nickander K. K., Tritschler H. J. The roles of oxidative stress and antioxidant. Treatment in experimental diabetic neuropathy. Diabetes: 1997; 46 01 S38 S42 (Pubitemid 27377396)
43. Luo J., Quan J., Tsai J. et al. Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism: 1998; 47 663 668 (Pubitemid 28265168)
44. Malcangio M., Tomlinson D. R. A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain: 1998; 76 151 157 (Pubitemid 28304951)
45. Meller S. T., Pechman P. S., Gebhart G. F. et al. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience: 1992; 50 7 10
46. nd ed. Seattle, Wa IASP Press: 1994
47. Mondelli M., Aretini A., Baldasseroni A. Distal symmetric polyneuropathy in diabetes. Differences between patients with and without neuropathic pain. Exp Clin Endocrinol Diabetes: 2012; 120 45 50
48. Mordes J. P., Bortell R., Blankenhorn E. P. et al. Rat models of type 1 diabetes: Genetics, environment, and autoimmunity. ILAR J: 2004; 45 277 290
49. Morrow T. J. Animal models of painful diabetic neuropathy: the STZ rat model. Curr Protoc Neurosci: 2004; Chapter 9 Unit 9.18
50. Mousa S. A., Shaqura M., Khalefa B. I. et al. Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy. Diabetes: 2013; 62 1308 1319
51. Nakamura J., Kato K., Hamada Y. et al. A protein kinase C-β-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes: 1999; 48 2090 2095 (Pubitemid 29458376)
52. Natarajan R., Nadlerm J. L. Lipoxygenases and lipid signaling in vascular cells in diabetes. Frontiers in Bioscience: 2003; 8 01 s783 s795 (Pubitemid 39140196)
53. Natarajan R., Nadler J. L. Lipid inflammatory mediators in diabetic vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology: 2004; 24 1542 1548 (Pubitemid 39180875)
54. Obrosova I. G., Drel V. R., Oltman C. L. et al. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab: 2007; 293 E1645 E1655 (Pubitemid 350255115)
55. Obrosova I. G., Van Huysen C., Fathallah L. et al. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. The FASEB Journal: 2002; 16 123 125
56. Obrosova I. G., Xu W., Lyzogubov V. V. et al. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic Biol Med: 2008; 44 972 981 (Pubitemid 351318144)
57. Obrosova I. G. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics: 2009; 6 638 647
58. Oltman C. L., Davidson E. P., Coppey L. J. et al. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin. Obesity (Silver Spring): 2008; 16 82 89 (Pubitemid 351271954)
59. Oltman C. L., Davidson E. P., Coppey L. J. et al. Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction. Diabetes Obes Metab: 2009; 11 223 233
60. Papanas N., Vinik A. I., Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol: 2011; 7 682 690
61. Pittenger G. L., Ray M., Burcus N. I. et al. Intraepidermal nerve fibers are indicators of small fiber neuropathy in both diabetic and non-diabetic patients. Diabetes Care: 2004; 27 1974 1979 69 (Pubitemid 38989241)
62. Pittenger G. L., Mehrabyan A., Simmons K. et al. Small fiber neuropathy is associated with the metabolic syndrome. Metabolic Syndrome and Related Disorders: 2005; 3 113 121 (Pubitemid 41269269)
63. Portha B., Giroix M. H., Serradas P. et al. Cellular basis for glucose refractoriness of pancreatic B-cells in non insulin dependent diabetes. In Flatt PR, Lenzen S. (eds.). Insulin secretion and pancreatic B cell research. UK Smith-Gordon: 1994; 461 472
64. Qiang X., Satoh J., Sagara M. et al. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced dia: betic rats. Diabetologia: 1998; 41 1321 1326 (Pubitemid 28488760)
65. Quattrini C., Harris N. D., Malik R. A. et al. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care: 2007; 30 655 659 (Pubitemid 46354348)
66. Ramos K. M., Jiang Y., Svensson C. I. et al. Pathogenesis of spinally mediated hyperalgesia in diabetes. Diabetes: 2007; 56 1569 1576 (Pubitemid 46842613)
67. Reed M. J., Meszaros K., Entes L. J. et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism: 2000; 49 1390 1394
68. Richard S., Jonathan S., Paul Z. et al. IDF Diabetes Atlas. fourth edition http://www.idf.org/diabetesatlas Accessed July 28: 2013
69. Schmidt R. E., Dorsey D. A., Beaudet lN et al. Analysis of the Zucker Diabetic Fatty (ZDF) Type 2 Diabetic Rat Model Suggests a Neurotrophic Role for Insulin/IGF-I in Diabetic Autonomic Neuropathy. Am J Pathol: 2003; 163 21 28 (Pubitemid 36759587)
70. Schreiber A. K., Neufeld M., Jesus C. H. et al. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats. Neuropharmacology: 2012; 63 1286 1297
71. Shafrir E., Ziv E., Mosthaf L. Nutritionally induced insulin resistance and receptor defect leading to b cell failure in animal models. Ann NY Acad Sci: 1999; 892 223 246
72. Shafrir E. Diabetes in animals: Contribution to the understanding of diabetes by study of its etiopathology in animal models. In: Porte D., Sherwin R. S., Baron A. (eds.). Diabetes mellitus. NewYork. McGraw-Hill: 2003; 231 255
73. Shun C. T., Chang Y. C., Wu H. P. et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain: 2004; 127 1593 1605
74. Sima A. A., Sugimoto K. Experimental diabetic neuropathy: An update. Diabetologia: 1999; 42 773 788 (Pubitemid 29325066)
75. Sima A. A., Zhang W., Xu G. et al. A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats. Diabetologia: 2000; 43 786 793 (Pubitemid 30409154)
76. Siwy J., Zoja C., Klein J. et al. Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles. PLoS One: 2012; 7 e51334
77. Srinivasan K., Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res: 2007; 125 451 472 (Pubitemid 46805458)
78. Sumner C. J., Sheth S., Griffin J. W. et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology: 2003; 60 108 111 (Pubitemid 36070653)
79. Surwit R. S., Kuhn C. M., Cochrane C. et al. Diet-induced type II diabetes in C57BL/6J mice. Diabetes: 1988; 37 1163 1167 (Pubitemid 19035045)
80. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physio Res: 2001; 50 536 546
81. Szkudelski T. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Experimental biology and medicine: 2012; 237 481 490
82. Tegeder I., Costigan M., Griffin R. S. et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med: 2006; 12 1269 1277 (Pubitemid 44706929)
83. Vareniuk I., Pavlov I. A., Obrosova I. G. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologi: 2008; 51 2126 2133
84. Velasquez M. T., Kimmel P. L., Michaelis O. E. IV. Animal models of spontaneous diabetic kidney disease. FASEB J: 1990; 4 2850 2859 (Pubitemid 120012531)
85. Vera G., López-Miranda V., Herradón E. et al. Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes. Pharmacol Biochem Behav: 2012; 102 335 343
86. Veves A., Backonja M., Malik R. A. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med: 2008; 9 660 674
87. Vinik A. I., Suwanwalaikorn S., Stansberry K. B. et al. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve: 1995; 18 574 584
88. Vogel H. G., Vogel WH. Drug discovery and evaluation; Pharmacological assays. Heidelberg, Berlin Springer-Verlag: 1997
89. Winzell M. S., Ahren B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes: 2004; 53 03 S215 S219 (Pubitemid 39564546)
90. WHO Country and regional data on diabetes http://www.who.int/diabetes/ facts/world-figures/en/ Accessed November 19,: 2013
91. Xu X., Liu Z., Liu H. et al. The effects of galanin on neuropathic pain in streptozotocin-induced diabetic rats. Eur J Pharmacol: 2012; 680 28 33
92. Yagihashi S., Yamagishi S. I., Wada R. I. et al. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain: 2001; 124 2448 2458 (Pubitemid 33134934)
93. Yan J. E., Yuan W., Lou X. et al. Streptozotocin-induced diabetic hyperalgesia in rats is associated with upregulation of Toll-like receptor 4 expression. Neurosci Lett: 2012; 526 54 58
94. Zhang F., Ye C., Li G. et al. The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp Anim: 2003; 52 401 407 (Pubitemid 41349948)
95. Zhang J. L., Yang J. P., Zhang J. R. et al. Gabapentin reduces allodynia and hyperalgesia in painful diabetic neuropathic rats by decreasing expression level of Nav1.7 and p-ERK1/2 in DRG neurons. Brain Res. 2013; Epub 2012 Nov 23